Literature DB >> 27701920

Status and advancement of microwave ablation in China.

Jie Yu1, Ping Liang1.   

Abstract

Tumour ablation is defined as the direct application of chemical or thermal therapy to eradicate or substantially destroy a tumour. Currently, minimally invasive ablation techniques are available for the local destruction of focal tumours in multiple organ sites. Microwave ablation (MWA) is premised on the biological response of solid tumours to tissue hyperthermia, and it is a relatively low-risk procedure. Due to several advantages of MWA, including higher thermal efficiency, higher capability for coagulating blood vessels, faster ablation time and the simultaneous application of multiple antennae, MWA could be a promising minimally invasive ablation technique for the treatment of solid tumours. Therefore, the use of MWA has developed rapidly in China during the last decade. Many successful studies have been performed, and widespread use has been achieved for multiple types of tumours in China, especially for liver cancer. This review will describe the state-of-the-art of MWA in China, including the development of MWA equipment and its application in the treatment of multiple types of tumours.

Entities:  

Keywords:  Microwave ablation; minimally invasive therapy; solid tumour

Year:  2016        PMID: 27701920     DOI: 10.1080/02656736.2016.1243261

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  8 in total

Review 1.  Local treatment of oligometastatic disease: current role.

Authors:  Moritz T Winkelmann; Stephan Clasen; Philippe L Pereira; Rüdiger Hoffmann
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

Review 2.  Efficacy and safety of cooled and uncooled microwave ablation for the treatment of benign thyroid nodules: a systematic review and meta-analysis.

Authors:  Bo-Wen Zheng; Jin-Fen Wang; Jin-Xiu Ju; Tao Wu; Ge Tong; Jie Ren
Journal:  Endocrine       Date:  2018-11       Impact factor: 3.633

3.  Image-Guided Percutaneous ‎Microwave Ablation Versus Cryoablation For Hepatocellular Carcinoma In High-Risk Locations: Intermediate-Term Results.

Authors:  Jiahui Hu; Sheng Chen; Xin Wang; Ning Lin; Jianchuan Yang; Songsong Wu
Journal:  Cancer Manag Res       Date:  2019-11-18       Impact factor: 3.989

4.  Toward a clinical real time tissue ablation technology: combining electroporation and electrolysis (E2).

Authors:  Enric Guenther; Nina Klein; Paul Mikus; Florin Botea; Mihail Pautov; Franco Lugnani; Matteo Macchioro; Irinel Popescu; Michael K Stehling; Boris Rubinsky
Journal:  PeerJ       Date:  2020-01-20       Impact factor: 2.984

Review 5.  Applications of Microwave Energy in Medicine.

Authors:  Alexandra Gartshore; Matt Kidd; Lovleen Tina Joshi
Journal:  Biosensors (Basel)       Date:  2021-03-26

6.  Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Zheng Li; Qiang Li; Xiaohu Wang; Weiqiang Chen; Xiaodong Jin; Xinguo Liu; Fei Ye; Zhongying Dai; Xiaogang Zheng; Ping Li; Chao Sun; Xiongxiong Liu; Qiuning Zhang; Hongtao Luo; Ruifeng Liu
Journal:  Cancer Med       Date:  2021-10-16       Impact factor: 4.452

7.  Nomogram based on albumin-bilirubin grade to predict outcome of the patients with hepatitis C virus-related hepatocellular carcinoma after microwave ablation.

Authors:  Chao An; Xin Li; Xiaoling Yu; Zhigang Cheng; Zhiyu Han; Fangyi Liu; Jie Yu; Ping Liang
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

8.  A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.

Authors:  Chao An; Songsong Wu; Zhimei Huang; Jiayan Ni; Mengxuan Zuo; Yangkui Gu; Tianqi Zhang; Jinhua Huang
Journal:  Cancer Med       Date:  2019-11-12       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.